These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 21974752

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adolescence fluoxetine increases serotonergic activity in the raphe-hippocampus axis and improves depression-like behaviors in female rats that experienced neonatal maternal separation.
    Yoo SB, Kim BT, Kim JY, Ryu V, Kang DW, Lee JH, Jahng JW.
    Psychoneuroendocrinology; 2013 Jun; 38(6):777-88. PubMed ID: 23010142
    [Abstract] [Full Text] [Related]

  • 10. Effects of combined administration of 5-HT1A and/or 5-HT1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats.
    Tatarczyńska E, Kłodzińska A, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2002 Jun; 54(6):615-23. PubMed ID: 12866716
    [Abstract] [Full Text] [Related]

  • 11. Effect of co-treatment with fluoxetine or mirtazapine and risperidone on the active behaviors and plasma corticosterone concentration in rats subjected to the forced swim test.
    Rogóż Z, Kabziński M, Sadaj W, Rachwalska P, Gądek-Michalska A.
    Pharmacol Rep; 2012 Jun; 64(6):1391-9. PubMed ID: 23406749
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of adolescent fluoxetine treatment on fear-, anxiety- or stress-related behaviors in C57BL/6J or BALB/cJ mice.
    Norcross M, Mathur P, Enoch AJ, Karlsson RM, Brigman JL, Cameron HA, Harvey-White J, Holmes A.
    Psychopharmacology (Berl); 2008 Oct; 200(3):413-24. PubMed ID: 18594797
    [Abstract] [Full Text] [Related]

  • 15. Extinction-induced "despair" in the water maze, exploratory behavior and fear: effects of chronic antidepressant treatment.
    Schulz D, Buddenberg T, Huston JP.
    Neurobiol Learn Mem; 2007 May; 87(4):624-34. PubMed ID: 17223365
    [Abstract] [Full Text] [Related]

  • 16. Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors.
    D'Souza DN, Zhang Y, Garcia F, Battaglia G, Van De Kar LD.
    Psychopharmacology (Berl); 2002 Dec; 164(4):392-400. PubMed ID: 12457269
    [Abstract] [Full Text] [Related]

  • 17. Standardised ginseng extract G115® potentiates the antidepressant-like properties of fluoxetine in the forced swim test.
    Terstege DJ, MacDonald DS, Tasker RA.
    Acta Neuropsychiatr; 2021 Jun; 33(3):141-147. PubMed ID: 33478610
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.